AI-Powered Pharmaceutical Intelligence Platform

Medical affairs and commercial teams relied on manual processes to collect scientific publications, clinical trial data, and congress information from multiple sources. Analysts downloaded records from research databases, manually removed duplicates, categorized information, and maintained spreadsheets to track evidence.

As research volumes increased, these manual workflows became difficult to manage, resulting in inconsistent data, limited traceability, delayed updates, and significant administrative effort across multiple teams.

We developed a multi-tenant pharmaceutical intelligence platform that automates the complete evidence management lifecycle.

The platform continuously ingests scientific literature, clinical trial data, and congress information from multiple sources, applies AI-assisted classification and metadata extraction, and routes content through a human review workflow before publication. Built on a shared SaaS architecture, the platform provides secure tenant isolation, centralized identity management, configurable feature access, and dedicated applications for evidence intelligence and congress planning.

This enables pharmaceutical organizations to manage scientific knowledge more efficiently while maintaining governance, security, and scalability.